Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $642.94 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $295.85 | 11 | $0 (2024) |
| AbbVie Inc. | $107.64 | 6 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $64.87 | 2 | $0 (2018) |
| Scilex Pharmaceuticals Inc. | $64.87 | 1 | $0 (2019) |
| Kaleo, Inc. | $46.15 | 1 | $0 (2019) |
| Eisai Inc. | $22.46 | 1 | $0 (2021) |
| PFIZER INC. | $21.28 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $19.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.94 | 1 | Novo Nordisk Inc ($20.94) |
| 2023 | $23.29 | 1 | Novo Nordisk Inc ($23.29) |
| 2022 | $79.09 | 4 | Novo Nordisk Inc ($79.09) |
| 2021 | $251.95 | 8 | Novo Nordisk Inc ($129.54) |
| 2020 | $42.99 | 2 | Novo Nordisk Inc ($42.99) |
| 2019 | $111.02 | 2 | Scilex Pharmaceuticals Inc. ($64.87) |
| 2018 | $113.66 | 6 | Janssen Pharmaceuticals, Inc ($64.87) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes | ||||||
| 01/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 12/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Diabetes | ||||||
| 09/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Diabetes | ||||||
| 08/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Diabetes | ||||||
| 06/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 12/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Diabetes | ||||||
| 11/30/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: VACCINES | ||||||
| 11/03/2021 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| 08/31/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 08/02/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: GASTROINTESTINAL | ||||||
| 07/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/27/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $101.89 | General |
| Category: Diabetes | ||||||
| 11/14/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes | ||||||
| 10/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Diabetes | ||||||
| 04/07/2019 | Kaleo, Inc. | EVZIO (Drug) | Food and Beverage | In-kind items and services | $46.15 | General |
| Category: OPIOID ANTAGONIST | ||||||
| 04/06/2019 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Food and Beverage | In-kind items and services | $64.87 | General |
| Category: Analgesic | ||||||
| 12/06/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Endocrinology | ||||||
| 10/04/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Endocrinology | ||||||
| 05/31/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $48.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Endocrinology | ||||||
| 04/17/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Endocrinology | ||||||
| 04/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 175 | 468 | $60,770 | $39,748 |
| 2022 | 9 | 310 | 736 | $78,800 | $55,161 |
| 2021 | 9 | 327 | 874 | $92,601 | $64,896 |
| 2020 | 17 | 538 | 1,254 | $121,785 | $82,692 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 134 | $20,080 | $13,773 | 68.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 157 | $18,740 | $11,127 | 59.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 95 | $11,300 | $8,310 | 73.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 40 | $8,340 | $4,470 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,015 | $1,825 | 90.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 29 | $295.00 | $243.60 | 82.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 177 | $25,520 | $18,518 | 72.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 195 | $21,435 | $14,684 | 68.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 16 | 132 | $15,730 | $10,184 | 64.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 47 | $9,400 | $6,766 | 72.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $4,050 | $3,879 | 95.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 11 | 11 | $990.00 | $648.07 | 65.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 91 | $910.00 | $269.88 | 29.7% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 22 | 41 | $615.00 | $159.77 | 26.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 15 | $150.00 | $51.56 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 236 | $35,180 | $25,559 | 72.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 238 | $25,440 | $17,609 | 69.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 14 | 105 | $12,570 | $8,275 | 65.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 56 | $10,840 | $7,821 | 72.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $3,150 | $3,079 | 97.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $2,940 | $1,854 | 63.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 57 | 110 | $1,106 | $328.00 | 29.7% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 30 | 83 | $1,245 | $326.19 | 26.2% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 13 | $130.00 | $45.24 | 34.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 226 | $29,245 | $19,752 | 67.5% |
About Dr. Eung Bai, MD
Dr. Eung Bai, MD is a General Practice healthcare provider based in Norwalk, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962412536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eung Bai, MD has received a total of $642.94 in payments from pharmaceutical and medical device companies, with $20.94 received in 2024. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($642.94).
As a Medicare-enrolled provider, Bai has provided services to 1,350 Medicare beneficiaries, totaling 3,332 services with total Medicare billing of $242,497. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Norwalk, CA
- Active Since 08/08/2006
- Last Updated 06/11/2019
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962412536
Products in Payments
- Ozempic (Drug) $123.14
- RYBELSUS (Drug) $114.50
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $64.87
- UBRELVY (Drug) $58.85
- Rybelsus (Drug) $58.21
- INVOKANA (Drug) $48.84
- Creon (Drug) $48.79
- EVZIO (Drug) $46.15
- COLOGUARD DNA CAPTURE REAGENTS (Device) $21.28
- SHINGRIX (Biological) $19.82
- XARELTO (Drug) $16.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Norwalk
Dr. Donna Grant, D.d.s, D.D.S
General Practice — Payments: $5,628
Dr. Sara Boren, Dds, DDS
General Practice — Payments: $3,088
Mr. Nghi Pham, Md, MD
General Practice — Payments: $2,000
Dr. Ethan Roos, D.d.s, D.D.S
General Practice — Payments: $1,579
Vandana Soni
General Practice — Payments: $1,534
Dr. Santo Delallo, Dmd, DMD
General Practice — Payments: $1,504